Cancer Prevention and Cancer Control Protocols

ANBL0032: Phase III Randomized Study of Chimeric Anti-GD2 in High Risk
Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue

Physician Summary: < age 30; High Risk: Anti-GD2 Following ASCR

70305: A Randomized Study to Prevent Lymphedema in Women Treated For Breast Cancer

Physician Summary: Newly Diagnosed Stage I – IV: Study to Prevent Lymphedema

369901: Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older with Operable, Newly Diagnosed Breast Cancer

Physician Summary: Chemotherapy Decisions/Outcomes in Women > 65 with Operable/Newly Diagnosed

NSABP B-43: A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

Physician Summary: ≥ age 18, Central HER2 Testing: RT +/- Trastuzumab

70305: A Randomized Study to Prevent Lymphedema in Women Treated For Breast Cancer

Physician Summary: Newly Diagnosed Stage I – IV: Study to Prevent Lymphedema

GOG 0256: A PROSPECTIVE STUDY OF COGNITIVE FUNCTION DURING CHEMOTHERAPY FOR FRONT-LINE TREATMENT IN OVARIAN, PRIMARY PERITONEAL OR FALLOPIAN TUBE CANCER

Physician Summary:

369901: Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older with Operable, Newly Diagnosed Breast Cancer

Physician Summary: Chemotherapy Decisions/Outcomes in Women > 65 with Operable/Newly Diagnosed

NSABP B-43: A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

Physician Summary: ≥ age 18, Central HER2 Testing: RT +/- Trastuzumab

MD Anderson 2006-0198: CAM Use and Cancer

Physician Summary: Nursing Study Only - Check with GRCOP at 616.391.1230

Open to Minorities Only   N08C7: A Phase III, Randomized, Placebo-controlled, Double-Blind Trial of Flaxseed for the Treatment of Hot Flashes

Physician Summary:

N08C1: Paclitaxel-Associated Acute Pain Syndrome Natural History Study

Please Note: Arm B Closed; Arm C may accrue minority patients only!

Physician Summary: ≥ age 18; Any Staging: Standard of Care with Use of Paclitaxel

RC08C6: White Wine for Appetite Loss: A Randomized, Controlled Non-blinded Trial

Physician Summary:

Closing August 31, 2010.  URCC 07004: Assessment of Topical Treatment Response with Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)

Physician Summary: ≥ age 18; Post Chemo; Symptoms Persisting ≥28 days: Amitriptyline/Ketamine Cream vs Placebo

N07C2: The Use of Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Physician Summary: ≥ age 18, Tx must be curative: Wisconsin Ginseng

2004-0024: Chemotherapy and Mindfulness Relaxation: A Randomized Trial At M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program

Physician Summary: Chemotherapy & Mindfulness Relaxation/Randomized Trial

SWOG S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastasis Starting Zoledronic Acid Treatment

Physician Summary: ≥ age 18; Bone Mets: Assess ONJ in Patients receiving Zometa

Closed to Accrual!  SELECT.  For documents related to the transitional phase of this study, go the the GRCOP Members Site.

Physician Summary:

Closed to Accrual!  SELECT.  For documents related to the transitional phase of this study, go the the GRCOP Members Site.

Physician Summary:

GOG 0256: A PROSPECTIVE STUDY OF COGNITIVE FUNCTION DURING CHEMOTHERAPY FOR FRONT-LINE TREATMENT IN OVARIAN, PRIMARY PERITONEAL OR FALLOPIAN TUBE CANCER

Physician Summary:

8461: Cytogenetic Studies In Acute Leukemia

Physician Summary: Previously Untreated AML, ALL, MDS: Bone Marrow and Blood Samples (Ancillary CALGB 9665 Required)

SWOG S9910: “Leukemia Centralized Reference Laboratories and Tissue Repositories, Ancillary”. (Ancillary study to S0535 and S0703)

Physician Summary: Ancillary study for S0535 & S0703

SWOG 9007: Cytogenetic Studies in Leukemia Patients, Ancillary (Ancillary study to S0535 & S0703)

Physician Summary:

Required Ancillary study to S0535 & S0703

SWOG 8947: Central Lymphoma Serum Repository Protocol (Ancillary to S0801)

Physician Summary: Suggested Ancillary study to S0801